Multiple Importations and Transmission of Colistin-resistant in a Hospital in Northern India
Overview
Infectious Diseases
Nursing
Public Health
Authors
Affiliations
Objective: Resistance to colistin, a last resort antibiotic, has emerged in India. We investigated colistin-resistant Klebsiella pneumoniae(ColR-KP) in a hospital in India to describe infections, characterize resistance of isolates, compare concordance of detection methods, and identify transmission events.
Design: Retrospective observational study.
Methods: Case-patients were defined as individuals from whom ColR-KP was isolated from a clinical specimen between January 2016 and October 2017. Isolates resistant to colistin by Vitek 2 were confirmed by broth microdilution (BMD). Isolates underwent colistin susceptibility testing by disk diffusion and whole-genome sequencing. Medical records were reviewed.
Results: Of 846 K. pneumoniae isolates, 34 (4%) were colistin resistant. In total, 22 case-patients were identified. Most (90%) were male; their median age was 33 years. Half were transferred from another hospital; 45% died. Case-patients were admitted for a median of 14 days before detection of ColR-KP. Also, 7 case-patients (32%) received colistin before detection of ColR-KP. All isolates were resistant to carbapenems and susceptible to tigecycline. Isolates resistant to colistin by Vitek 2 were also resistant by BMD; 2 ColR-KP isolates were resistant by disk diffusion. Moreover, 8 multilocus sequence types were identified. Isolates were negative for mobile colistin resistance (mcr) genes. Based on sequencing analysis, in-hospital transmission may have occurred with 8 case-patients (38%).
Conclusions: Multiple infections caused by highly resistant, mcr-negative ColR-KP with substantial mortality were identified. Disk diffusion correlated poorly with Vitek 2 and BMD for detection of ColR-KP. Sequencing indicated multiple importation and in-hospital transmission events. Enhanced detection for ColR-KP may be warranted in India.
Yadav K, Datkhile K, Pawar S, Patil S Cureus. 2025; 17(2):e78800.
PMID: 40078264 PMC: 11902915. DOI: 10.7759/cureus.78800.
Khurana S, Katiyar A, Puraswani M, Sharma D, Walia K, Malhotra R Future Sci OA. 2023; 9(10):FSO896.
PMID: 37753358 PMC: 10518808. DOI: 10.2144/fsoa-2022-0055.
Sundermann A, Chen J, Miller J, Martin E, Snyder G, Van Tyne D Antimicrob Steward Healthc Epidemiol. 2022; 2(1):e91.
PMID: 36483409 PMC: 9726481. DOI: 10.1017/ash.2021.241.
Evaluation of Vitek®2 performance for colistin susceptibility testing for Gram-negative isolates.
Khurana S, Malhotra R, Mathur P JAC Antimicrob Resist. 2021; 2(4):dlaa101.
PMID: 34223053 PMC: 8210208. DOI: 10.1093/jacamr/dlaa101.